Document:

Exhibit 10.1

Exhibit 10.1

Portside Growth and Opportunity Fund

c/o Ramius LLC

599 Lexington Avenue, 20th Floor

New York, New York 10022

December 29, 2009

Image Entertainment, Inc.

20525 Nordhoff Street, Suite 200

Chatsworth, California 91311

Attention: Jeff Framer

			
	Re:	 	Payoff of Convertible Note 

Dear Sirs:

Reference is hereby made to that certain Amended and Restated Senior Secured Convertible Note
(the “Note”), dated as of July 30, 2009, as further amended to date, made by Image Entertainment,
Inc., a Delaware corporation (the “Company”), in favor of Portside Growth and Opportunity Fund
(“Portside”). Capitalized terms used but not defined herein shall have the meanings assigned to
them in the Purchase Agreement (as defined below).

On December 21, 2009, the Company entered into a Securities Purchase Agreement (the “Purchase
Agreement”) with JH Partners, LLC, as Investor Representative (the “Investor Representative”), and
the Investors named therein. Portside understands that Investors have the right to terminate the
Purchase Agreement on December 29, 2009 if Investors and the Company have not achieved a reduction
in obligations to the Company’s creditors that is satisfactory to Investors in their sole
discretion, and Investors will be acting in reliance on this letter (the “Payoff Letter”) if they
elect not to exercise their right to terminate the Purchase Agreement. In order to induce
Investors to forego their right to terminate the Purchase Agreement and to complete the
transactions to be completed at the Initial Closing (as defined in the Purchase Agreement) under
the Purchase Agreement and to make an investment in the Company, a portion of the proceeds of which
will be paid to Portside, Portside has agreed to deliver to Investors this Agreement setting forth
the amount required to be paid in cash and shares of the Company’s common stock on the Initial
Closing Date (as defined in the Purchase Agreement) by or on behalf of the Company to Portside in
order to pay in full and fully satisfy and discharge the Note.

This Payoff Letter will confirm that, upon receipt by you of the Payoff Amount (as defined
below) in accordance with this Payoff Letter, all of the obligations of the Company under the Note
shall be terminated.

Payoff Amount. (a) On the Initial Closing Date, the Company shall pay to Portside
cash in the amount of $15,000,000.00 (the “Cash Payment”) and issue to Portside 3,500,000 shares of
the Company’s common stock, par value $0.0001 per share (the “Shares,” and together with the Cash
Payment, the “Payoff Amount”). The Company, or the Investors on behalf of the Company, shall pay
the Cash Payment to Portside pursuant to wire transfer instructions to be provided by Portside to
the Company and the Investors at least two business days prior to the Initial Closing Date.

 

 

 

(b) The Shares shall be issued to Portside (i) in exchange for $10,000 in principal amount of
the Note pursuant to an exchange agreement (“Exchange Agreement”) to be reasonably agreed between
the Company and Portside and (ii) in reliance upon the exemption from registration provided by
Section 3(a)(9) of the Securities Act of 1933, as amended. The Exchange Agreement shall contain
representations and warranties and closing conditions substantially the same as those set forth in
the sample Exchange Agreement provided by Portside to the Investors by email on December 29, 2009,
except that the Company shall not be required to make any representations regarding its listing
status on a Principal Market (as defined in the Note) or the absence of a default under the Note,
and the exchange shall not be conditioned on the Company’s common stock continuing to be listed on
a Principal Market. The Exchange Agreement will contain the Company’s acknowledgement that the
holding period of the Shares may be tacked onto the holding period of the Notes and the Company’s
agreement not to take a contrary position. Furthermore, the Exchange Agreement will provide that
the Company agrees to take all actions, including, without limitation, the issuance by its legal
counsel of any reasonably necessary legal opinions, necessary to issue Shares that are freely
tradable on the principal exchange or quotation service on which the Company’s common stock is then
listed or quoted without restriction and not containing any restrictive legend, in each case
without the need for any action by the Investor. The Exchange Agreement will require the Company
to use commercially reasonable efforts to maintain a market for quotation and trading of its common
stock, such as the Pink sheets or the OTCBB if the common stock is not listed on Nasdaq, and will
not take actions to inhibit the quotation and trading of its common stock on any such market. In
respect of the Shares to be delivered to Portside, the Company shall deliver to Portside a copy of
irrevocable transfer agent instructions to its transfer agent Computershare Investor Services (the
“Transfer Agent”), dated the Initial Closing Date, authorizing and instructing the Transfer Agent
to issue the Shares to Portside.

Termination of Obligations. Upon (a) our receipt of the Cash Payment, (b) execution
of the Exchange Agreement by the Company and Portside and (c) our receipt of the irrevocable
transfer agent instructions to issue the Shares in accordance with this Payoff Letter and the
Exchange Agreement, (i) all indebtedness for borrowed money and any other obligations of the
Company under the Note, including without limitation the principal, interest, premium and any other
amounts whatsoever due under the Note, shall be fully paid, satisfied, discharged and released, and
the Note shall be terminated; and (ii) all security interests, mortgages, guaranties, pledges and
other liens granted to or held by Portside and any other secured parties under the security
documents securing the Note shall be forever satisfied, released and discharged without further
action.

Treatment of Warrants. The Company hereby acknowledges and agrees that (i) the
transaction contemplated by the Purchase Agreement constitutes a “Dilutive Issuance”as defined in
the Amended and Restated Warrants dated November 10, 2006, as further amended to date, issued by
the Company to Portside (the “Warrants”) and (ii) in accordance with Section 4(b) of the Warrants,
payment of the Black-Scholes Value of the Warrants by the Company to Portside as a result of the
transaction contemplated by the Purchase Agreement shall be solely at the option of Portside and
not the Company.

No Assignment. Portside has sole, good and marketable title to, and owns of record
and beneficially, the Note, free and clear of any and all liens. No other person has any right,
title or interest in the Note. Portside does not have an obligation of any kind or nature,
absolute or contingent, to any other person to sell, assign, transfer or otherwise dispose of, and
has not entered into any contract, option or other arrangement or understanding with respect to the
direct or indirect sale, assignment, transfer or other disposition of, the Note (other than this
Payoff Letter).

 

-2-

 

Miscellaneous. The Investor Representative and the Investors are intended third-party
beneficiaries of this Payoff Letter. This Payoff Letter may be signed by the parties hereto in
several counterparts. Delivery of a photocopy or facsimile of an executed counterpart of this
Payoff Letter shall be effective as delivery of a manually executed original counterpart of this
Payoff Letter. The validity, construction and effect of this Payoff Letter shall be governed by
the laws of the State of New York (without giving effect to principles of conflicts of law).

Termination. This Payoff Letter shall terminate and be of no further force or effect upon the
earlier of (i) the termination of the Purchase Agreement and (ii) January 9, 2010 if the Initial
Closing has not been completed on January 8, 2009.

 

-3-

 

Very truly yours,

	 	 	 
	 	PORTSIDE GROWTH AND OPPORTUNITY FUND
	 
	 	By:  	/s/ OWEN LITTMAN
	 	 	Name: Owen Littman 
	 	 	Title: Authorized Signatory 
	 

AGREED AND ACCEPTED:

	 	 	 	 	 
	IMAGE ENTERTAINMENT, INC.

 	 	 
	By:  	/s/ JEFF M. FRAMER	 	 
	Name:  	Jeff M. Framer	 	 
	Title:  	President and Chief Financial Officer	 	 
	 	1/7/10 	 	 
	 

 

-4-exv10w1

Exhibit 10.1

EXECUTION VERSION

KANSAS CITY SOUTHERN de MÉXICO, S.A. de C.V.

$300,000,000 8% Senior Notes due 2018

PLACEMENT AGREEMENT

January 7, 2010

 

 

January 7, 2010

Banc of America Securities LLC

J.P. Morgan Securities Inc.

Scotia Capital (USA) Inc.

BBVA Securities Inc.

BMO Capital Markets Corp.

			
	c/o	 	Banc of America Securities LLC

One Bryant Park

New York, New York 10036

Dear Sirs and Mesdames:

     Kansas City Southern de México, S.A. de C.V. (formerly known as TFM, S.A. de C.V.) (the
“Company”), a sociedad anónima de capital variable organized under the laws of the United Mexican
States (“Mexico”), proposes to issue and sell to the several purchasers named in Schedule I hereto
(the “Placement Agents”), acting through Banc of America Securities LLC as representative (the
“Representative”), $300,000,000 aggregate principal amount of its 8% Senior Notes due February 1,
2018 (the “Securities”) to be issued pursuant to the provisions of an Indenture to be executed on
or about January 22, 2010 (the “Indenture”) between the Company and U.S. Bank National Association,
as Trustee (the “Trustee”).

     The Securities will be offered without being registered under the Securities Act of 1933, as
amended (the “Securities Act”), to qualified institutional buyers in compliance with the exemption
from registration provided by Rule 144A under the Securities Act, in offshore transactions in
reliance on Regulation S under the Securities Act (“Regulation S”) and to institutional accredited
investors (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act) that deliver a
letter in the form annexed to the Final Memorandum (as defined below).

     The Placement Agents and their direct and indirect transferees will be entitled to the
benefits of a Registration Rights Agreement to be executed on or about January 22, 2010 between the
Company and the Placement Agents (the “Registration Rights Agreement”).

     In connection with the sale of the Securities, the Company has prepared a preliminary offering
memorandum (the “Preliminary Memorandum”) and will prepare a final offering memorandum (the “Final
Memorandum” and, with the Preliminary Memorandum, each a “Memorandum”) including or incorporating
by reference a description of the terms of the Securities, the terms of the offering and a
description of the Company. “Time of Sale Memorandum” means the

1

 

Preliminary Memorandum together with the information set forth on Schedule II to this
Agreement that has been prepared and delivered by the Company to the Placement Agents in connection
with the offering of the Securities. The “Applicable Time” means 5:42 p.m. Eastern Standard Time
on January 7, 2010. Reference to “this Agreement” shall mean this Placement Agreement.

     1. Representations and Warranties. The Company represents and warrants to, and agrees with,
you that:

     (a) (i) The Time of Sale Memorandum, at the Applicable Time, did not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not
misleading, and (ii) the Preliminary Memorandum does not contain and the Final Memorandum,
as of its date and as of the Closing Date (as defined below), will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not
misleading, except that the representations and warranties set forth in this paragraph do
not apply to statements or omissions in the Time of Sale Memorandum or either Memorandum
based upon information relating to any Placement Agent furnished to the Company in writing
by such Placement Agent through you expressly for use therein, it being understood and
agreed that the only such information furnished by or on behalf of any Placement Agent
consists of the information described as such in Section 8(b) hereof.

     (b) The Company (including its agents and representatives, other than the Placement
Agents in their capacity as such) has not prepared, made, used, authorized, approved or
referred to and will not prepare, make, use, authorize, approve or refer to any written
communication that constitutes an offer to sell or solicitation of an offer to buy the
Securities (an “Issuer Written Communication”) (other than the Final Memorandum, the Time
of Sale Memorandum and any electronic roadshow).

     (c) The Company has been duly incorporated, is validly existing as a sociedad anónima
de capital variable under the laws of Mexico in good standing (to the extent applicable),
has the corporate power and authority to own, lease and operate its property and to
conduct its business as described in the Time of Sale Memorandum and each Memorandum and
is duly qualified to transact business and is in good standing (to the extent applicable)
in each jurisdiction in which the conduct of its business or its ownership or leasing of
property requires such qualification, except to the extent that the failure to be so
qualified or be in good standing (to the extent applicable) would not reasonably be

2

 

expected to have a material adverse effect on the Company and its subsidiaries, taken
as a whole.

     (d) Each of the subsidiaries of the Company has been duly organized, is validly
existing and in good standing (to the extent applicable) under the laws of the
jurisdiction of its incorporation, has the corporate power and authority to own, lease and
operate its property and to conduct its business as described in the Time of Sale
Memorandum and each Memorandum and is duly qualified to transact business and is in good
standing (to the extent applicable) in each jurisdiction in which the conduct of its
business or its ownership or leasing of property requires such qualification, except to
the extent that the failure to be so qualified or be in good standing (to the extent
applicable) would not reasonably be expected to have a material adverse effect on the
Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock
of each of the subsidiaries held by the Company have been duly and validly authorized and
issued, are fully paid and non-assessable and are owned directly or indirectly by the
Company, free and clear of all liens, encumbrances, equities or claims.

     (e) This Agreement has been duly authorized, executed and delivered by the Company.

     (f) The capitalization of the Company conforms as to legal matters to the description
thereof contained in the Time of Sale Memorandum and the Final Memorandum.

     (g) The Securities have been duly authorized and, when executed and authenticated in
accordance with the provisions of the Indenture and delivered to and paid for by the
Placement Agents in accordance with the terms of this Agreement, will be valid and binding
obligations of the Company, enforceable in accordance with their terms, subject to
applicable concurso mercantil, bankruptcy, insolvency and similar laws affecting
creditors’ rights generally and equitable principles of general applicability, and will be
entitled to the benefits of the Indenture pursuant to which such Securities are to be
issued, and the Registration Rights Agreement.

     (h) The Registration Rights Agreement has been duly authorized and, on the Closing
Date (as defined below), will have been duly executed and delivered by, and will
constitute a valid and binding agreement of, the Company, enforceable in accordance with
its terms, except as the enforcement thereof may be limited by applicable concurso
mercantil, bankruptcy, insolvency and similar laws affecting creditors’ rights generally
and equitable principles of general applicability and

3

 

except as rights to indemnification under the Registration Rights Agreement may be
limited by applicable law.

     (i) The Indenture has been duly authorized by the Company and, at the Closing Date
(as defined below), will have been duly executed and delivered by the Company and will
constitute a valid and binding agreement of the Company, enforceable against the Company
in accordance with its terms, except as the enforcement thereof may be limited by
applicable concurso mercantil, bankruptcy, insolvency and similar laws affecting
creditors’ rights generally and equitable principles of general applicability. On the
Closing Date (as defined below), the Indenture will conform in all material respects to
the requirements of the Trust Indenture Act of 1939, as amended (the “TIA”), applicable to
an indenture qualified thereunder.

     (j) The execution and delivery by the Company of, and the performance by the Company
of its obligations under this Agreement, the Indenture, the Registration Rights Agreement
and the Securities (the “Transaction Documents”) and the consummation of the transactions
contemplated therein have been duly authorized by the Company, the Company has all power
and authority to execute, deliver and perform its obligations under the Transaction
Documents and the execution, delivery and performance by the Company of its obligations
under the Transaction Documents and the consummation of the transactions contemplated
therein, including, without limitation, the application of the proceeds from the sale of
the Securities as described in the Memorandum and the Time of Sale Memorandum, will not
(i) contravene, conflict with or constitute a breach of, or default under any provision of
(x) the estatutos sociales or any other organizational document of the Company or any of
its subsidiaries, (y) the Concession (as defined below) or any law applicable to the
Company and its operations (including, without limitation, its subsidiaries) or (z) any
agreement or other instrument binding upon the Company, any of its subsidiaries or Kansas
City Southern (“KCS”) that is included in or incorporated by reference into the Annual
Report on Form 10-K for the year ended December 31, 2008, the Quarterly Report on Form
10-Q for the quarter ended March 31, 2009, the Quarterly Report on Form 10-Q for the
quarter ended June 30, 2009 and the Quarterly Report on Form 10-Q for the quarter ended
September 30, 2009 of the Company or KCS, (ii) result in an event or condition which gives
the holder of any note, debenture, or other evidence of indebtedness that is included in
or incorporated by reference into the Annual Report on Form 10-K for the year ended
December 31, 2008, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009,
the Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 and the Quarterly
Report on Form 10-Q for the quarter ended September 30, 2009 of the Company or KCS (or any

4

 

person acting on such holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company or any of
its subsidiaries, or (iii) contravene, conflict with or constitute a breach of, or default
under any judgment, order or decree of any governmental body, agency or court having
jurisdiction over the Company or any of its subsidiaries and their respective operations,
except to the extent that such violation, breach or default described in item (iii) of
this Section 1(g) would not reasonably be expected to have a material adverse effect on
the Company and its subsidiaries, taken as a whole.

     (k) No consent, approval, authorization or order of, or qualification with, any
governmental body or agency is required for the performance by the Company of its
obligations under the Transaction Documents, except (i) such as may be required (x) by the
securities or Blue Sky laws of the various states in connection with the offer and sale of
the Securities, (y) by U.S. Federal and state securities laws with respect to the
Company’s obligations under the Registration Rights Agreement, and (z) the filing of a
notice with the Comisión Nacional Bancaria y de Valores of Mexico (the “CNBV”) regarding
the issuance of the Securities and the terms thereof, such filing to be delivered by the
Company to the CNBV prior to the Closing Date (as defined below), and (ii) such consents,
approvals, authorizations, filings or orders as have been obtained.

     (l) The Company holds a valid concession title granted in 1997 for a period of 50
years, which may be renewed under certain conditions for an additional period of up to 50
years, to provide freight transportation services over its rail lines as described in the
Time of Sale Memorandum and the Final Memorandum (the “Concession”). The Concession is
currently, and has at all times since its granting been, in full force and effect and no
proceeding to revoke, suspend or lapse the effectiveness of the Concession is pending
before or, to the Company’s knowledge, threatened by any Mexican federal governmental
authority. Except for the rights held by the government of Mexico as described in the
Time of Sale Memorandum and the Final Memorandum, the Concession and the Company’s rights
deriving therefrom are free and clear of any liens and encumbrances.

     (m) The Company and each of its subsidiaries own, possess or has obtained all
licenses, permits, certificates, consents, orders, approvals and other authorizations
from, including, without limitation, the Concession, and has made all declarations and
filings with, all federal, state, local and other governmental authorities (including
foreign regulatory agencies), all self-regulatory organizations and all courts and other
tribunals, domestic or foreign, necessary to own or lease, as the case

5

 

may be, and to operate its properties and to carry on its business as conducted as of
the date hereof and as described in the Time of Sale Memorandum and the Final Memorandum,
except to the extent that the failure to own, possess or obtain such licenses, permits,
certificates, consents, orders, approvals and other authorizations would not reasonably be
expected to have a material adverse effect on the Company and its subsidiaries, taken as a
whole; and neither the Company nor any of its subsidiaries has received any notice of any
proceeding relating to revocation or modification of any such license, permit,
certificate, consent, order, approval or other authorization which, individually or in the
aggregate, if subject to an unfavorable or adverse decision or ruling, would reasonably be
expected to result in a material adverse effect on the Company and its subsidiaries, taken
as a whole.

     (n) The historical audited consolidated financial statements and notes thereto of the
Company included, or incorporated by reference, in the Time of Sale Memorandum and the
Final Memorandum (i) have been prepared in accordance with U.S. generally accepted
accounting principles (“U.S. GAAP”) (prior historical audited consolidated financial
statements and notes of the Company prepared in accordance with International Financial
Reporting Standards (“IFRS”) have been re-stated in accordance with U.S. GAAP), (ii)
present fairly in all material respects the financial condition, results of operations and
cash flows of the Company and each of its subsidiaries taken as a whole, and (iii) comply
as to form in all material respects with the applicable accounting requirements of the
Securities Act which would be applicable if the offer of the Securities were required to
be registered under the Securities Act; the summary financial data in the Time of Sale
Memorandum and the Final Memorandum, including all items reconciled to U.S. GAAP, fairly
present, on the basis stated in the Time of Sale Memorandum and the Final Memorandum, the
information included therein. No other financial statements are required to be included
in the Time of Sale Memorandum or the Final Memorandum.

     (o) The Company and each of its subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are executed in
accordance with management’s general or specific authorizations; (ii) all transactions are
recorded as necessary to permit preparation of financial statements in accordance with
U.S. GAAP and to maintain asset accountability; (iii) access to assets is permitted only
in accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences.

6

 

     (p) KPMG Cárdenas Dosal, S.C., who has audited the consolidated financial statements
of the Company and its subsidiaries and delivered its report with respect to the
consolidated financial statements of the Company and its subsidiaries as of December 31,
2006 included, or incorporated by reference, in the Time of Sale Memorandum and the Final
Memorandum, are independent public accountants with respect to the Company within the
meaning and as required by the Securities Act and all the applicable rules and regulations
published thereunder and the rules and regulations of the Public Company Accounting
Oversight Board. KPMG LLP (“KPMG”), who has audited the consolidated financial statements
of the Company and its subsidiaries and delivered its report with respect to the
consolidated financial statements of the Company and its subsidiaries as of December 31,
2007 and December 31, 2008 included, or incorporated by reference, in the Time of Sale
Memorandum and the Final Memorandum, are independent public accountants with respect to
the Company within the meaning and as required by the Securities Act and all the
applicable rules and regulations published thereunder and the rules and regulations of the
Public Company Accounting Oversight Board.

     (q) The Company and each of its subsidiaries has filed all tax returns (foreign,
national, local or other) required to be filed and has paid all taxes required to be paid
by it and any other assessment, fine or penalty levied against it, to the extent that any
of the foregoing is due and payable, except for any such assessment, fine or penalty that
is currently being contested in good faith and except where the failure to file or pay
would not, individually or in the aggregate, result in a material adverse effect on the
Company and its subsidiaries, taken as a whole.

     (r) Except as described in the Time of Sale Memorandum and Final Memorandum, payments
in respect of the Transaction Documents (including the transfer, sale and delivery of the
Securities), are not subject under the current laws of any applicable jurisdiction or any
political subdivision thereof or therein to any withholdings or similar charges for or on
account of taxation or otherwise other than taxes imposed on the income or gain of the
Placement Agents whose net income or gains are otherwise subject to any tax by Mexico or
any political subdivision thereof or therein.

     (s) Except as described in the Time of Sale Memorandum and Final Memorandum, payments
made to a foreign holder (as defined in the Time of Sale Memorandum and each Memorandum)
by the Company under the Securities will not be subject under the current laws of Mexico
or any political subdivision thereof to any withholdings or similar charges for or on
account of taxation.

7

 

     (t) Except as described in the Time of Sale Memorandum and Final Memorandum,
non-Mexican holders of the Securities will not be deemed resident, domiciled, carrying on
business or subject to taxation in Mexico solely by reason of the execution, delivery,
performance or enforcement of each of the Transaction Documents.

     (u) There are no stamp or other issuance or transfer taxes or duties or other similar
fees or charges required to be paid in connection with the execution and delivery of this
Agreement or the issuance or sale by the Company of the Securities.

     (v) Since the respective dates as of which information is given in the Time of Sale
Memorandum and each Memorandum, there has not occurred any material adverse change, or any
development involving a prospective material adverse change, in the condition, financial
or otherwise, or in the earnings, business or operations of the Company and its
subsidiaries, taken as a whole, from that set forth in the Preliminary Memorandum.

     (w) Neither the Company nor any of its subsidiaries is (i) in violation, breach of,
or default under any provision of (x) the estatutos sociales or any other organizational
document of the Company or any of its subsidiaries, (y) the Concession or any law
applicable to the Company and its operations (including, without limitation, its
subsidiaries) or (z) any agreement or other instrument binding upon the Company, any of
its subsidiaries or KCS that is included in or incorporated by reference into the Annual
Report on Form 10-K for the year ended December 31, 2008, the Quarterly Report on Form
10-Q for the quarter ended March 31, 2009, the Quarterly Report on Form 10-Q for the
quarter ended June 30, 2009 and the Quarterly Report on Form 10-Q for the quarter ended
September 30, 2009 of the Company or KCS , (ii) currently subject to an event or condition
which gives the holder of any note, debenture, or other evidence of indebtedness that is
included in or incorporated by reference into the Annual Report on Form 10-K for the year
ended December 31, 2008, the Quarterly Report on Form 10-Q for the quarter ended March 31,
2009, the Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 and the
Quarterly Report on Form 10-Q for the quarter ended September 30, 2009 of the Company or
KCS (or any person acting on such holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company or its
subsidiaries, or (iii) in violation, breach of, or default under any judgment, order or
decree of any governmental body, agency or court having jurisdiction over the Company or
any of its subsidiaries, except to the extent that any such violation, breach or default
described in items (i)(z) or (iii) of this Section

8

 

1(t) would not reasonably be expected to have a material adverse effect on the
Company and its subsidiaries, taken as a whole.

     (x) There are no legal or governmental proceedings pending or, to the Company’s
knowledge, threatened to which the Company or any of its subsidiaries is a party or to
which any of the properties of the Company or any of its subsidiaries is subject other
than proceedings that are accurately described in all material respects in the Time of
Sale Memorandum and each Memorandum and proceedings that would not reasonably be expected
to have a material adverse effect on the Company and its subsidiaries, taken as a whole,
or on the power or ability of the Company to perform its obligations under the Transaction
Documents or to consummate the transactions contemplated by the Time of Sale Memorandum
and the Final Memorandum.

     (y) The Company and each of its subsidiaries (i) are in compliance with any and all
applicable foreign, federal, state and municipal laws and regulations relating to the
protection of human health and safety, the environment or hazardous or toxic substances or
wastes, pollutants or contaminants, including, without limitation, the environmental
obligations under the Concession (“Environmental Laws”), (ii) have received all permits,
licenses or other approvals required of them under applicable Environmental Laws to
conduct their respective businesses and (iii) are in compliance with all terms and
conditions of any such permit, license or approval, except where such noncompliance with
Environmental Laws, failure to receive required permits, licenses or other approvals or
failure to comply with the terms and conditions of such permits, licenses or approvals
would not, singly or in the aggregate, have a material adverse effect on the Company and
its subsidiaries, taken as a whole.

     (z) There are no costs or liabilities associated with Environmental Laws (including,
without limitation, any capital or operating expenditures required for clean-up, closure
of properties or compliance with Environmental Laws or any permit, license or approval,
any related constraints on operating activities and any potential liabilities to third
parties) which would, singly or in the aggregate, have a material adverse effect on the
Company and its subsidiaries, taken as a whole.

     (aa) No labor dispute with the employees of the Company or any of its subsidiaries
exists or, to the knowledge of the Company or any of its subsidiaries, is threatened or,
to the Company’s knowledge, is imminent, and to the knowledge of the Company and any of
its subsidiaries there is no existing or imminent labor disturbance by the employees of
any of their respective principal suppliers, contractors or

9

 

customers that would be reasonably likely to have a material adverse effect on the
Company and its subsidiaries, taken as a whole.

     (bb) The Company and each of its subsidiaries have not, nor to the knowledge of the
Company, has any director, officer, agent, employee or other person associated with or
acting on behalf of the Company or any of its subsidiaries, used any of the funds of the
Company or any of its subsidiaries for any contribution, gift, entertainment or other
expense relating to political activity in contravention of any applicable law, made any
direct or indirect payment to any foreign or domestic government official or employee in
contravention of any applicable law from any of the funds of the Company or any of its
subsidiaries, or made any bribe, rebate, payoff influence payment, kickback or other
unlawful payment in contravention of any applicable law, including the U.S. Foreign
Corrupt Practices Act.

     (cc) The Company and each of its subsidiaries is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent
and customary for companies engaged in the same or similar businesses; all such policies
covering any of their business, assets, employees, officers and directors are in full
force and effect; the Company and each of its subsidiaries is in compliance with the terms
of such policies and instruments in all material respects; and there are no claims by the
Company or any of its subsidiaries under any such policy or instrument as to which any
insurance company is denying liability or defending under a reservation of rights clause;
and neither the Company nor any of its subsidiaries has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage expires or
to obtain similar coverage from similar insurers as may be necessary to continue their
businesses.

     (dd) The Company and each of its subsidiaries have no immunity from jurisdiction of
any court of (i) any jurisdiction in which they own or lease property or assets, (ii) the
United States or the State of New York or (iii) Mexico or any political subdivision
thereof or from any legal process (whether through service of notice, attachment prior to
judgment, attachment in aid of execution, execution or otherwise) with respect to
themselves or their property and assets or this Agreement, the Indenture or the
Registration Rights Agreement or actions to enforce judgments in respect thereof.

     (ee) No relationship, direct or indirect, exists between the Company or any of its
subsidiaries on the one hand, and the directors, officers, stockholders, customers or
suppliers of the Company or any of its subsidiaries on the other hand, which would be
required by the Securities

10

 

Act, if the offer of the Securities were required to be registered under the
Securities Act, to be described in the Time of Sale Memorandum and the Final Memorandum
which is not so described.

     (ff) The Company is not and does not expect to become a passive foreign investment
company as defined in Section 1297 of the U.S. Internal Revenue Code of 1986, as amended,
and the regulations promulgated thereunder.

     (gg) Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department.

     (hh) The Company and each of its subsidiaries are in material compliance with
applicable Mexican and U.S. anti-terrorism and anti-money laundering rules and
regulations, including Title III of the USA Patriot Act, the regulations administered by
the U.S. Department of the Treasury, including its Office of Foreign Assets Control, and
other applicable Mexican and U.S. federal, state or non-U.S. anti-money laundering laws
and regulations (collectively, the “Money Laundering Laws”) and no action, suit or
proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its subsidiaries with respect to the Money
Laundering Laws is pending, to the knowledge of the Company, or threatened.

     (ii) The Company is subject to and is reporting in accordance with the requirements
of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) and all documents incorporated by reference in the Time of Sale Memorandum
and the Final Memorandum comply as to form in all material respects with the applicable
requirements of the Exchange Act.

     (jj) The Company has not paid or agreed to pay to any person any compensation for
soliciting another to purchase any securities of the Company, except as contemplated in
this Agreement.

     (kk) The statements in, or incorporated by reference in, the Time of Sale Memorandum
and the Final Memorandum under the headings “Capitalization”, “Business”, “Description of
the Notes”, and “Taxation” fairly summarize the matters therein described.

     (ll) There is and has been no failure on the part of the Company and to the Company’s
knowledge, after reasonable inquiry, any of the Company’s directors or officers, in their
capacities as such, to comply

11

 

with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith (the “Sarbanes-Oxley Act”) applicable to the Company
as of the date hereof.

     (mm) Until March 31, 2005 the Company was a “foreign issuer” (as defined in
Regulation S). Since April 1, 2005, the Company has been a “domestic issuer” (as defined
in Regulation S) and has adopted all the necessary measures consistent with its status as
such, and the Company reasonably believes that there is no substantial U.S. market
interest (as defined in Regulation S) in its debt securities.

     (nn) The Company is not, and after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the Time of Sale
Memorandum and the Final Memorandum will not be, required to register as an “investment
company” as such term is defined in the Investment Company Act of 1940, as amended.

     (oo) Neither the Company nor any affiliate (as defined in Rule 501(b) of Regulation D
under the Securities Act, and, for avoidance of doubt, including KCS, an “Affiliate”)) of
the Company has directly, or through any agent, (i) sold, offered for sale, solicited
offers to buy or otherwise negotiated in respect of, any security (as defined in the
Securities Act) which is or will be integrated with the sale of the Securities in a manner
that would require the registration under the Securities Act of the Securities or (ii)
offered, solicited offers to buy or sold the Securities by any form of general
solicitation or general advertising (as those terms are used in Regulation D under the
Securities Act) or in any manner involving a public offering within the meaning of Section
4(2) of the Securities Act.

     (pp) None of the Company, its Affiliates or any person acting on its or their behalf
has engaged or will engage in any directed selling efforts (within the meaning of
Regulation S) with respect to the Securities and the Company and its Affiliates and any
person acting on its or their behalf have complied and will comply with the offering
restrictions requirement of Regulation S.

     (qq) It is not necessary in connection with the offer, sale and delivery of the
Securities to the Placement Agents in the manner contemplated by this Agreement to
register the Securities under the Securities Act or to qualify the Indenture under the
TIA.

     (rr) The Securities satisfy the requirements set forth in Rule 144A(d)(3) under the
Securities Act.

12

 

     (ss) The Company has validly, legally, effectively and irrevocably submitted to the
personal jurisdiction of any state or Federal court in the Borough of Manhattan, The City
of New York, New York, has validly, legally, effectively and irrevocably waived any
objection to the venue of a proceeding in any such court, and has validly, legally,
effectively and irrevocably appointed C T Corporation System as its authorized agent for
service of process.

     2. Agreements to Sell and Purchase. The Company hereby agrees to sell to the several
Placement Agents, and each Placement Agent, upon the basis of the representations and warranties
herein contained, but subject to the conditions hereinafter stated, agrees, severally and not
jointly, to purchase from the Company the aggregate principal amount of the Securities set forth in
Schedule I hereto opposite its name at a purchase price of 96.55% of the aggregate principal amount
thereof (the “Purchase Price”).

     The Company hereby agrees that, without the prior written consent of the Representative, it
will not, during the period beginning on the date hereof and continuing to and including the
Closing Date (as defined below), offer, sell, contract to sell or otherwise dispose of any debt of
the Company or warrants to purchase debt of the Company substantially similar to the Securities
(other than the sale of the Securities under this Agreement).

     3. Terms of Offering. You have advised the Company that the Placement Agents will make an
offering of the Securities purchased by the Placement Agents hereunder on the terms to be set forth
in the Time of Sale Memorandum, as soon as practicable after this Agreement is entered into as in
your judgment is advisable.

     4. Payment and Delivery. Payment for the Securities shall be made to the Company in Federal
or other funds immediately available in New York City against delivery of such Securities for the
respective accounts of the several Placement Agents at 10:00 a.m., New York City time, on January
22, 2010, or at such other time on the same or such other date, not later than January 22, 2010, as
shall be designated in writing by you. The time and date of such payment are hereinafter referred
to as the “Closing Date.”

     The Securities shall be in definitive form or global form, as specified by you, and registered
in such names and in such denominations as you shall request in writing not later than one full
business day prior to the Closing Date. The Securities shall be delivered to you on the Closing
Date for the respective accounts of the several Placement Agents, with any transfer taxes payable
in connection with the transfer of the Securities to the Placement Agents duly paid, against
payment of the Purchase Price therefor.

13

 

     5. Conditions to the Placement Agents’ Obligations. The several obligations of the
Placement Agents to purchase and pay for the Securities on the Closing Date are subject to the
following conditions:

     (a) Subsequent to the execution and delivery of this Agreement and on or prior to the
Closing Date:

     (i) there shall not have occurred any downgrading, nor shall any notice
have been given of any intended or potential downgrading or of any review for a
possible change that does not indicate the direction of the possible change, in
the rating accorded the Company or any of the securities of the Company, KCS or
any of their subsidiaries or in the rating outlook for the Company by any
“nationally recognized statistical rating organization,” as such term is defined
for purposes of Rule 436(g)(2) under the Securities Act;

     (ii) the Company shall have obtained all consents, approvals,
authorizations and orders of, and shall have duly made all registrations,
qualifications and filings with, any court or regulatory authority or other
governmental agency or instrumentality, including without limitation the CNBV,
required in connection with the issuance and sale of the Securities and the
execution, delivery and performance of this Agreement; and

     (iii) there shall not have occurred any change, or any development
involving a prospective change, in the condition, financial or otherwise, or in
the earnings, business or operations of the Company and its subsidiaries, taken
as a whole, from that set forth in the Time of Sale Memorandum provided to
prospective purchasers of the Securities that, in your reasonable judgment, is
material and adverse and that makes it, in your reasonable judgment,
impracticable or inadvisable to proceed with the offer, sale or delivery of the
Securities on the terms and in the manner contemplated in the Time of Sale
Memorandum.

     (b) The Placement Agents shall have received on the Closing Date a certificate, dated
the Closing Date and signed by an executive officer of the Company, to the effect set
forth in Section 5(a)(i) and to the effect that the representations and warranties of the
Company contained in this Agreement are true and correct as of the Closing Date and that
the Company has complied with all of the agreements and satisfied all of the conditions on
its part to be performed or satisfied hereunder on or before the Closing Date. The officer
signing and delivering such certificate may rely upon his or her knowledge as to
proceedings threatened.

14

 

     (c) The Placement Agents shall have received on the Closing Date an opinion of
Sonnenschein Nath & Rosenthal LLP, outside U.S. counsel for the Company, dated the Closing
Date, in form and substance satisfactory to the Representative. Such opinion shall be
rendered to the Placement Agents at the request of the Company and shall so state therein.

     (d) The Placement Agents shall have received on the Closing Date an opinion of White
& Case, S.C., outside Mexican counsel for the Company, dated the Closing Date, in form and
substance reasonably satisfactory to the Representative. Such opinion shall be rendered
to the Placement Agents at the request of the Company and shall so state therein.

     (e) The Placement Agents shall have received on the Closing Date an in-house legal
opinion from Edgar Aguileta Gutiérrez, Associate General Counsel and Alternate Corporate
Secretary of the Company, dated the Closing Date, in form and substance reasonably
satisfactory to the Representative. Such opinion shall be rendered to the Placement
Agents at the request of the Company and shall so state therein.

     (f) The Placement Agents shall have received on the Closing Date an opinion of
Shearman & Sterling LLP, U.S. counsel for the Placement Agents, dated the Closing Date, in
form and substance reasonably satisfactory to the Representative.

     (g) The Placement Agents shall have received on the Closing Date an opinion of
Mijares, Angoitia, Cortés y Fuentes, S.C., Mexican counsel for the Placement Agents, dated
the Closing Date, in form and substance reasonably satisfactory to the Representative.

     (h) The Placement Agents shall have received on each of the date hereof and the
Closing Date a letter, dated the date hereof or the Closing Date, as the case may be, in
form and substance satisfactory to the Representative, from KPMG, independent public
accountants, containing statements and information of the type ordinarily included in
accountants’ “comfort letters” to underwriters with respect to the financial statements
and certain financial information contained in the Time of Sale Memorandum and the Final
Memorandum; provided, however, that the letter delivered on the Closing Date shall use a
“cut-off date” not earlier than the date hereof.

     (i) The Placement Agents shall have received on the date hereof a letter, dated the
date hereof, in form and substance satisfactory to the Representative, from KPMG Cárdenas
Dosal, S.C., independent public accountants, containing statements and information of the
type ordinarily included in accountants’ “comfort letters” to underwriters with respect to

15

 

the financial statements and certain financial information contained in the Time of Sale
Memorandum and the Final Memorandum

     (j) As of the Closing Date, the Company shall have entered into the Registration
Rights Agreement and the Placement Agents shall have received executed counterparts
thereof.

     (k) As of the Closing Date, the Company and the Trustee shall have entered into the
Indenture and the Placement Agents shall have received executed counterparts thereof.

     6. Covenants of the Company. In further consideration of the agreements of the Placement
Agents contained in this Agreement, the Company covenants with each Placement Agent as follows:

     (a) To furnish to you in New York City, without charge, prior to 10:00 a.m., New York
City time on the business day next succeeding the date of this Agreement and during the
period mentioned in Section 6(b), as many electronic copies of the Time of Sale
Memorandum, either Memorandum and any supplements and amendments thereto as you may
reasonably request.

     (b) Before amending or supplementing the Time of Sale Memorandum or either
Memorandum, to furnish to you a copy of each such proposed amendment or supplement and not
to use any such proposed amendment or supplement to which you reasonably object, provided
that if, in the opinion of counsel to the Company, any such amendment or supplement shall
be required by law or regulation to be used, that the Company be permitted to use such
amendment or supplement after taking into account such comments as you may reasonably make
on the content, form or other aspects of such amendment or supplement. In addition,
before making, preparing, using, authorizing, approving or distributing any Issuer Written
Communication, the Company will furnish to the Representative a copy of such Issuer
Written Communication for review and will not make, prepare, use, authorize, approve or
distribute any such Issuer Written Communication to which the Representative reasonably
objects.

     (c) If the Time of Sale Memorandum is being used to solicit offers to buy the
Securities at a time when the Final Memorandum is not yet available to prospective
purchasers and any event shall occur or condition exist as a result of which it is
necessary to amend or supplement the Time of Sale Memorandum in order to make the
statements therein, in the light of the circumstances, not misleading, or if, in the
opinion of counsel for the Placement Agents, it is necessary to amend or supplement

16

 

the Time of Sale Memorandum to comply with applicable law, forthwith to prepare and furnish,
at the Company’s own expense, to the Placement Agents upon request, either amendments or
supplements to the Time of Sale Memorandum so that the statements in the Time of Sale
Memorandum as so amended or supplemented will not, in the light of the
circumstances when delivered to a prospective purchaser, be misleading or so that the
Time of Sale Memorandum, as amended or supplemented, will comply with law.

     (d) If, during such period after the date hereof and prior to the date on which all
of the Securities shall have been sold by the Placement Agents, any event shall occur or
condition exist as a result of which it is necessary to amend or supplement the Final
Memorandum in order to make the statements therein, in the light of the circumstances when
the Final Memorandum is delivered to a purchaser, not misleading, or if, in the opinion of
counsel for the Placement Agents, it is necessary to amend or supplement the Final
Memorandum to comply with applicable law, forthwith to prepare and furnish, at its own
expense, to the Placement Agents, either amendments or supplements to the Final Memorandum
so that the statements in the Final Memorandum as so amended or supplemented will not, in
the light of the circumstances when the Final Memorandum is delivered to a purchaser, be
misleading or so that the Final Memorandum, as amended or supplemented, will comply with
applicable law.

     (e) To endeavor to qualify the Securities for offer and sale under the securities or
Blue Sky laws of such jurisdictions as you shall reasonably request.

     (f) Whether or not the transactions contemplated in this Agreement are consummated or
this Agreement is terminated, to pay or cause to be paid all expenses incident to the
performance of its obligations under this Agreement. It is understood, however, that
except as provided in this Section, Section 8, and the last paragraph of Section 10, or as
otherwise agreed by the parties hereto in writing, the Placement Agents will pay all of
their costs and expenses, including fees and disbursements of their counsel, transfer
taxes payable on resale of any of the Securities by them and any advertising expenses
connected with any offers they may make.

     (g) Neither the Company nor any Affiliate will sell, offer for sale or solicit offers
to buy or otherwise negotiate in respect of any security (as defined in the Securities
Act) which could be integrated with the sale of the Securities in a manner which would
require the registration under the Securities Act of the Securities.

17

 

     (h) Not to solicit any offer to buy or offer or sell the Securities by means of any
form of general solicitation or general advertising (as those terms are used in Regulation
D under the Securities Act) or in any manner involving a public offering within the
meaning of Section 4(2) of the Securities Act.

     (i) While any of the Securities remain “restricted securities” within the meaning of
the Securities Act, to make available, upon request, to any seller of such Securities the
information specified in Rule 144A(d)(4) under the Securities Act, unless the Company is
then subject to Section 13 or 15(d) of the Exchange Act.

     (j) None of the Company, its Affiliates or any person acting on its or their behalf
(other than the Placement Agents) will engage in any directed selling efforts (as that
term is defined in Regulation S) with respect to the Securities, and the Company and its
Affiliates and each person acting on its or their behalf (other than the Placement Agents)
will comply with the offering restrictions requirement of Regulation S.

     (k) During the period of one year after the Closing Date, the Company will not, and
will not permit any of its affiliates (as defined in Rule 144 under the Securities Act) to
resell any of the Securities which constitute “restricted securities” under Rule 144 that
have been reacquired by any of them.

     (l) Not to take any action prohibited by Regulation M under the Exchange Act in
connection with the distribution of the Securities contemplated hereby.

     (m) To comply in all material respects with all applicable securities and other laws,
rules and regulations, including without limitation, the Sarbanes-Oxley Act, and to cause
the officers and directors of the Company, in their capacities as such, to comply with
such laws, rules and regulations, including without limitation, the provisions of the
Sarbanes-Oxley Act.

     (n) To comply in all material respects with all matters imposed under the U.S.
securities laws applicable, from and after April 1, 2005, to entities that are not foreign
private issuers under such laws, including, to the extent applicable, the preparation of
the Company’s consolidated financial statements from and after January 1, 2005 under U.S.
GAAP.

     7. Offering of Securities; Restrictions on Transfer. (a) Each Placement Agent, severally and
not jointly, represents and warrants that such Placement Agent is a qualified institutional buyer
as defined in Rule 144A under the Securities Act (a “QIB”). Each Placement Agent, severally and
not jointly,

18

 

agrees with the Company that (i) it will not solicit offers for, or offer or sell,
such Securities by any form of general solicitation or general advertising (as those terms are used
in Regulation D under the Securities Act) or in any manner involving a public offering within the
meaning of Section 4(2) of the Securities Act and (ii) it will solicit offers for such Securities
only from, and will offer such Securities only to, persons that it reasonably believes to be (A) in
the case of offers inside the United States, QIBs and (B) in the case of offers outside the
United States, to persons other than U.S. persons (“foreign purchasers,” which term shall
include dealers or other professional fiduciaries in the United States acting on a discretionary
basis for foreign beneficial owners (other than an estate or trust)) in reliance upon Regulation S
under the Securities Act that, in each case, in purchasing such Securities are deemed to have
represented and agreed as provided in the Time of Sale Memorandum under the caption “Transfer
Restrictions”.

     (b) Each Placement Agent, severally and not jointly, represents, warrants, and agrees with
respect to offers and sales outside the United States that:

     (i) such Placement Agent understands that no action has been or will be taken in any
jurisdiction by the Company that would permit a public offering of the Securities, or
possession or distribution of the Time of Sale Memorandum or either Memorandum or any
other offering or publicity material relating to the Securities, in any country or
jurisdiction where action for that purpose is required;

     (ii) such Placement Agent will comply with all applicable laws and regulations in
each jurisdiction in which it acquires, offers, sells or delivers Securities or has in
its possession or distributes the Time of Sale memorandum or either Memorandum or any
such other material, in all cases at its own expense;

     (iii) the Securities have not been registered under the Securities Act and may not
be offered or sold within the United States or to, or for the account or benefit of, U.S.
persons except in accordance with Rule 144A or Regulation S under the Securities Act or
pursuant to another exemption from the registration requirements of the Securities Act;

     (iv) such Placement Agent has offered the Securities and will offer and sell the
Securities (A) as part of their distribution at any time and (B) otherwise until 40 days
after the later of the commencement of the offering and the Closing Date, only in
accordance with Rule 903 of Regulation S or as otherwise permitted in Section 7(a);
accordingly, neither such Placement Agent, its Affiliates nor any persons acting on its

19

 

or their behalf have engaged or will engage in any directed selling efforts (within the
meaning of Regulation S) with respect to the Securities, and any such Placement Agent,
its Affiliates and any such persons have complied and will comply with the offering
restrictions requirement of Regulation S;

     (v) such Placement Agent (A) has only communicated or caused to be communicated and
will only communicate or cause to be communicated an invitation or inducement to engage
in investment
activity (within the meaning of Section 21 of the Financial Services and Markets Act
2000 (the “FSMA”)) received by it in connection with the offer of the Securities in
circumstances in which Section 21(1) of the FSMA does not apply to the Company; and (B)
it has complied and will comply with all applicable provisions of the FSMA with respect
to anything done by it in relation to the Securities in, from or otherwise involving the
United Kingdom;

     (vi) such Placement Agent understands that the Securities have not been and will not
be registered with the Registro Nacional de Valores (National Registry of Securities)
maintained by the CNBV under the Securities and Exchange Law of Mexico (Ley del Mercado
de Valores), and represents that it has not offered or sold, and agrees not to offer or
sell, directly or indirectly, any Securities in Mexico or for the account of any resident
thereof, except pursuant to a private placement exemption set forth under Article 8 of
the Securities and Exchange Law of Mexico and in compliance with applicable provisions of
Mexican Law or in accordance with an authorization to that effect; and

     (vii) such Placement Agent agrees that, at or prior to confirmation of sales of the
Securities, it will have sent to each distributor, dealer or person receiving a selling
concession, fee or other remuneration that purchases Securities from it during the
restricted period a confirmation or notice to substantially the following effect:

     “The Securities covered hereby have not been registered under the U.S.
Securities Act of 1933 (the “Securities Act”) and may not be offered and sold
within the United States or to, or for the account or benefit of, U.S. persons
(i) as part of their distribution at any time or (ii) otherwise until 40 days
after the later of the commencement of the offering and the closing date, except
in either case in accordance with Regulation S (or Rule 144A if available) under
the Securities Act. Terms used above have the meaning given to them by
Regulation S.”

Terms used in this Section 7(b) have the meanings given to them by Regulation S.

20

 

     8. Indemnity and Contribution. (a) The Company agrees to indemnify and hold harmless each
Placement Agent, each person, if any, who controls any Placement Agent within the meaning of either
Section 15 of the Securities Act or Section 20 of the Exchange Act, and each affiliate of any
Placement Agent within the meaning of Rule 405 under the Securities Act from and against any and
all losses, claims, damages and liabilities (including, without limitation, any legal or other
expenses reasonably incurred in connection with defending or investigating any such action or
claim) caused by any untrue statement or alleged untrue statement of a material fact contained in
the Time of Sale Memorandum or either Memorandum or any amendments or supplements thereto, or any
of the
supplemental marketing materials listed on Schedule III hereto, or caused by any omission or
alleged omission to state therein a material fact necessary to make the statements therein in the
light of the circumstances under which they were made not misleading, except insofar as such
losses, claims, damages or liabilities are caused by any such untrue statement or omission or
alleged untrue statement or omission based upon information relating to any Placement Agent
furnished to the Company in writing by such Placement Agent through you expressly for use therein,
it being understood and agreed that the only such information furnished by or on behalf of any
Placement Agent consists of the information described as such in Section 8(b) hereof.

     (b) Each Placement Agent agrees, severally and not jointly, to indemnify and hold harmless the
Company, its directors, its officers and each person, if any, who controls the Company within the
meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act to the same
extent as the foregoing indemnity from the Company to such Placement Agent, but only with reference
to information relating to such Placement Agent furnished to the Company in writing by such
Placement Agent through you expressly for use in the Time of Sale Memorandum or either Memorandum
or any amendments or supplements thereto. The Company acknowledges that (i) the last full
paragraph of the cover page of each Memorandum, (ii) the third sentence of the second full
paragraph under the caption “Private Placement” in each Memorandum, (iii) the first sentence of the
seventh full paragraph under the caption “Private Placement” in each Memorandum, (iii) the eighth
full paragraph under the caption “Private Placement” in each Memorandum and (iv) the eleventh full
paragraph under the caption “Private Placement” in each Memorandum constitute the only information
furnished in writing by or on behalf of the Placement Agents for inclusion in the documents
referred to in the foregoing indemnity.

     (c) In case any proceeding (including any governmental investigation) shall be instituted
involving any person in respect of which indemnity may be sought pursuant to Section 8(a) or 8(b),
such person (the “indemnified party”) shall promptly notify the person against whom such indemnity
may be sought (the “indemnifying party”) in writing and the indemnifying party, upon request of the
indemnified party, shall retain counsel reasonably satisfactory to the indemnified

21

 

party to represent the indemnified party and any others the indemnifying party may designate in such
proceeding and shall pay the fees and disbursements of such counsel related to such proceeding. In
any such proceeding, any indemnified party shall have the right to retain its own counsel, but the
fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the
indemnifying party and the indemnified party shall have mutually agreed to the retention of such
counsel, (ii) the named parties to any such proceeding (including any impleaded parties) include
both the indemnifying party and the indemnified party and representation of both parties by the
same counsel would be inappropriate due to actual or potential differing interests between them,
(iii) the indemnifying party has failed within a reasonable time to retain counsel reasonably
satisfactory to the indemnified party or (iv) the indemnified party has
reasonably concluded that there may be legal defenses available to it which are different from
or in addition to those available to the indemnifying party. It is understood that the indemnifying
party shall not, in respect of the legal expenses of any indemnified party in connection with any
proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of
more than one separate firm (in addition to any local counsel) for all such indemnified parties and
that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be
designated in writing by the Representative, in the case of parties indemnified pursuant to Section
8(a), and by the Company, in the case of parties indemnified pursuant to Section 8(b). The
indemnifying party shall not be liable for any settlement of any proceeding effected without its
written consent, but if settled with such consent or if there be a final judgment for the
plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any
loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing
sentence, if at any time an indemnified party shall have requested an indemnifying party to
reimburse the indemnified party for fees and expenses of counsel as contemplated by the second and
third sentences of this paragraph, the indemnifying party agrees that it shall be liable for any
settlement of any proceeding effected without its written consent if (i) such settlement is entered
into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii)
such indemnifying party shall not have reimbursed the indemnified party in accordance with such
request prior to the date of such settlement. No indemnifying party shall, without the prior
written consent of the indemnified party, effect any settlement of any pending or threatened
proceeding in respect of which any indemnified party is or could have been a party and indemnity
could have been sought hereunder by such indemnified party, unless (i) such settlement includes an
unconditional release of such indemnified party from all liability on claims that are the subject
matter of such proceeding and (ii) does not include any statements as to or any findings of fault,
culpability or failure to act by or on behalf of any indemnified party.

     (d) To the extent the indemnification provided for in Section 8(a) or 8(b) is unavailable to
an indemnified party or insufficient in respect of any losses,

22

 

claims, damages or liabilities
referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying
such indemnified party thereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, claims, damages or liabilities (i) in such proportion
as is appropriate to reflect the relative benefits received by the Company on the one hand and the
Placement Agents on the other hand from the offering of the Securities or (ii) if the allocation
provided by clause 8(d)(i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but also
the relative fault of the Company on the one hand and of the Placement Agents on the other hand in
connection with the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The relative benefits received
by the Company on the one hand and the Placement Agents on the other hand in connection with the
offering of the Securities shall be
deemed to be in the same respective proportions as the net proceeds from the offering of the
Securities (before deducting expenses) received by the Company and the total discounts and
commissions (after deducting reimbursements for expenses incurred by the Company) received by the
Placement Agents, in each case as set forth in the Time of Sale Memorandum and the Final
Memorandum, bear to the aggregate offering price of the Securities. The relative fault of the
Company on the one hand and of the Placement Agents on the other hand shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the
Company or by the Placement Agents and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. The Placement
Agents’ respective obligations to contribute pursuant to this Section 8 are several in proportions
to the respective principal amount of Securities they have purchased hereunder, and not joint.

     (e) The Company and the Placement Agents agree that it would not be just or equitable if
contribution pursuant to Section 8(d) were determined by pro rata allocation (even if the Placement
Agents were treated as one entity for such purpose) or by any other method of allocation that does
not take account of the equitable considerations referred to in Section 8(d). The amount paid or
payable by an indemnified party as a result of the losses, claims, damages and liabilities referred
to in Section 8(d) shall be deemed to include, subject to the limitations set forth above, any
legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim. Notwithstanding the provisions of this
Section 8, no Placement Agent shall be required to contribute any amount in excess of the discount
and commissions received by it in connection with the Securities distributed by it. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The remedies provided for in this

23

 

Section 8 are not exclusive and shall not
limit any rights or remedies, which may otherwise be available to any indemnified party at law or
in equity.

     (f) The indemnity and contribution provisions contained in this Section 8 and the
representations, warranties and other statements of the Company contained in this Agreement shall
remain operative and in full force and effect regardless of (i) any termination of this Agreement,
(ii) any investigation made by or on behalf of any Placement Agent, any person controlling any
Placement Agent or any affiliate of any Placement Agent or by or on behalf of the Company, its
officers or directors or any person controlling the Company and (iii) acceptance of and payment for
any of the Securities.

     9. Termination. The Placement Agents may terminate this Agreement by notice given by you to
the Company, if after the execution and delivery of this Agreement and prior to the Closing Date
(i) trading generally shall have been suspended or materially limited on, or by, as the case may
be, any of the New
York Stock Exchange, the American Stock Exchange, the Nasdaq Global Market, the Chicago Board
of Options Exchange, the Chicago Mercantile Exchange, the Chicago Board of Trade, or Bolsa Mexicana
de Valores, S.A. de C.V., (ii) trading of any securities of the Company or KCS shall have been
suspended on any exchange or in any over-the-counter market, (iii) a material disruption in
securities settlement, payment or clearance services in the United States or Mexico shall have
occurred, (iv) any moratorium on commercial banking activities shall have been declared by Federal
or New York State or Mexican authorities or (v) there shall have occurred any outbreak or
escalation of hostilities, or any change in financial markets, currency exchange rates or controls
or any calamity or crisis that, in your judgment, is material and adverse and which, singly or
together with any other event specified in this clause (v), makes it, in your judgment,
impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities on the
terms and in the manner contemplated in the Time of Sale Memorandum or the Final Memorandum.

     10. Effectiveness; Defaulting Placement Agents. (a) This Agreement shall become effective
upon the execution and delivery hereof by the parties hereto.

     (b) If, on the Closing Date, any one or more of the Placement Agents shall fail or refuse to
purchase Securities that it or they have agreed to purchase hereunder on such date, and the
aggregate principal amount of Securities which such defaulting Placement Agent or Placement Agents
agreed but failed or refused to purchase is not more than one-tenth of the aggregate principal
amount of Securities to be purchased on such date, the other Placement Agents shall be obligated
severally in the proportions that the principal amount of Securities set forth opposite their
respective names in Schedule I bears to the aggregate principal amount of Securities set forth
opposite the names of all such

24

 

non-defaulting Placement Agents, or in such other proportions as you
may specify, to purchase the Securities which such defaulting Placement Agent or Placement Agents
agreed but failed or refused to purchase on such date; provided that in no event shall the
principal amount of Securities that any Placement Agent has agreed to purchase pursuant to this
Agreement be increased pursuant to this Section 10 by an amount in excess of one-ninth of such
principal amount of Securities without the written consent of such Placement Agent. If, on the
Closing Date any Placement Agent or Placement Agents shall fail or refuse to purchase Securities
which it or they have agreed to purchase hereunder on such date and the aggregate principal amount
of Securities with respect to which such default occurs is more than one-tenth of the aggregate
principal amount of Securities to be purchased on such date, and arrangements satisfactory to you
and the Company for the purchase of such Securities are not made within 36 hours after such
default, this Agreement shall terminate without liability on the part of any non-defaulting
Placement Agent or of the Company. In any such case either you or the Company shall have the right
to postpone the Closing Date, but in no event for longer than seven days, in order that the
required changes, if any, in the Time of Sale Memorandum or the Final Memorandum or in any other
documents or
arrangements may be effected. Any action taken under this paragraph shall not relieve any
defaulting Placement Agent from liability in respect of any default of such Placement Agent under
this Agreement.

     (c) If this Agreement shall be terminated by the Placement Agents, or any of them, because of
any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the
conditions of this Agreement, or if for any reason the Company shall be unable to perform its
obligations under this Agreement, the Company will reimburse the Placement Agents or such Placement
Agents as have so terminated this Agreement with respect to themselves, severally, for all
out-of-pocket expenses (including the fees and disbursements of their counsel) reasonably incurred
by such Placement Agents in connection with this Agreement or the offering contemplated hereunder.

     11. Entire Agreement. This Agreement, together with any contemporaneous written agreements
and any prior written agreements (to the extent not superseded by this Agreement) that relate to
the offering of the Securities, represents the entire agreement between the Company and the
Placement Agents with respect to the preparation of the Time of Sale Memorandum, either Memorandum,
the conduct of the offering, and the purchase and sale of the Securities.

     12. No Fiduciary Duties. The Company acknowledges and agrees that the Placement Agents are
acting solely in the capacity of an arm’s length contractual counterparty to the Company with
respect to the Offer (including in connection with determining the terms of the Offer) and not as
financial advisors or as fiduciaries to, or agents of, the Company or any other person.
Additionally,

25

 

the Placement Agents are not advising the Company or any other person as to any
legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall
consult with its own advisors concerning such matters and shall be responsible for making its own
independent investigation and appraisal of the transactions contemplated hereby, and the Placement
Agents shall have no responsibility or liability to the Company with respect thereto. Any review
by the Placement Agents of the Company, the transactions contemplated hereby or other matters
relating to such transactions will be performed solely for the benefit of the Placement Agents and
shall not be on behalf of the Company.

     13. Counterparts. This Agreement may be signed in any number of counterparts, each of which
shall be an original, with the same effect as if the signatures thereto and hereto were upon the
same instrument.

     14. Consent to Jurisdiction. Appointment of Agent to Accept Service of Process.

     (a) Each of the Placement Agents and the Company irrevocably consents and agrees that any
legal action, suit or proceeding against it with respect to is obligations, liabilities or any
other matter arising out of or based on this
Agreement may be brought in any United Sates federal or sate court in the State of New York,
County of New York. Each of the parties irrevocably and unconditionally waives, to the fullest
extent permitted by law, any objection that it may now or hereafter have to the laying of venue of
any of the aforesaid actions, suits or proceedings arising out of or in connection with this
Agreement, the Registration Rights Agreement, the Indenture and the Securities brought in the
federal courts located in the City of New York or the courts of the State of New York located in
the County of New York and hereby further irrevocably and unconditionally waives and agrees, to the
fullest extent permitted by law, not to plead or claim in any such court that any such action, suit
or proceeding brought in any such court has been brought in an inconvenient forum, hereby waiving
the venue of any other court to which they may have a right based on their domicile or otherwise.

     (b) The Company designates, appoints, and empowers C T Corporation System, with offices
currently at 111 Eight Avenue, New York, New York 10011, as its designee, appointee and agent to
receive and forward for and on its behalf, service of any and all legal process, summons, notices
and documents that may be served in any action, suit or proceeding brought against any of the
liabilities or any other matter arising out of or in connection with this Agreement, the
Registration Rights Agreement, the Indenture and the Securities that may be on such designee,
appointee and agent in accordance with legal procedures prescribed for such courts. If for any
reason such designee, appointee and agent hereunder shall cease to be available to act as such, the
Company agrees to designate a new designee, appointee and agent in The City of New York

26

 

on the
terms and for the purposes of this Section 14 reasonably satisfactory to the Placement Agents. The
Company further hereby irrevocably consents and agrees to the service of any legal process,
summons, notices and documents in any such action, suit or proceeding against the Company by
serving a copy thereof upon the relevant agent of service of process referred to in this Section 14
(whether or not the appointment of such agent shall for any reason prove to be ineffective or such
agent shall accept or acknowledge such service). The Company agrees that the failure of any such
designee, appointee and agent to give any notice of such service to them shall not impair or affect
in any way the validity of such service or any judgment rendered in any action or proceeding based
thereon. Nothing herein shall in any way be deemed to limit the ability of the Placement Agents to
serve any such legal process, summons, notices and documents in any other manner permitted by
applicable law or to obtain jurisdiction over the Company or bring actions, suits or proceedings
against them in such other jurisdictions, and in such manner, as may be permitted by applicable
law.

     15. Judgment Currency. If for the purposes of obtaining judgment in any court it is necessary
to convert a sum due hereunder into any currency other than U.S. dollars, the parties hereto agree,
to the fullest extent that they may effectively do so, that the rate of exchange used shall be the
rate at which in accordance with normal banking procedures the Placement Agents could purchase U.S.
dollars with such other currency in The City of New York on the business
day preceding that on which final judgment is given. The obligations of the Company in
respect of any sum due from it to any Placement Agent shall, notwithstanding any judgment in any
currency other than U.S. dollars, not be discharged until the first business day, following receipt
by such Placement Agent of any sum adjudged to be so due in such other currency, on which (and only
to the extent that) such Placement Agent may in accordance with normal banking procedures purchase
U.S. dollars with such other currency; if the U.S. dollars so purchased are less than the sum
originally due to such Placement Agent hereunder, the Company agrees, as a separate obligation and
notwithstanding any such judgment, to indemnify such Placement Agent against such loss. If the
U.S. dollars so purchased are greater than the sum originally due to such Placement Agent
hereunder, such Placement Agent agrees to pay to the Company an amount equal to the excess of the
U.S. dollars so purchased over the sum originally due to such Placement Agent hereunder.

     16. Applicable Law. This Agreement shall be governed by and construed in accordance with the
internal laws of the State of New York.

27

 

     17. Headings. The headings of the sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed a part of this Agreement.

     18. Notices. All communications hereunder shall be in writing and effective only upon receipt
and if to the Placement Agents shall be delivered, mailed or sent to Banc of America Securities
LLC, One Bryant Park, New York, New York 10036, Attention: High Yield Capital Markets Syndicate
Desk; and if to the Company shall be delivered, mailed or sent to Kansas City Southern de México,
S.A. de C.V., Montes Urales No. 625, Col. Lomas de Chapultepec, Delegación Miguel Hidalgo, 11000,
México D.F., Attention: Chief Financial Officer.

28

 

	 	 	 	 	 
	 	Very truly yours,

KANSAS CITY SOUTHERN de MÉXICO, S.A. de C.V.

 	 
	 	By:  	/s/ Paul J. Weyandt
 	 
	 	 	Name:  	Paul J. Weyandt 	 
	 	 	Title:  	Treasurer & Attorney-in-fact 	 
	 

Accepted as of the date hereof

Banc of America Securities LLC

Acting severally on behalf of themselves and the

several Placement Agents named in Schedule I

hereto.

	 	 	 	 	 
	 	 	 
	By:  	Banc of America Securities LLC
 	 	 
	 	 	 	 
	 	 	 
	By:  	/s/ Stephen Jaeger
 	 	 
	 	Name:  	Stephen Jaeger 	 	 
	 	Title:  	Managing Director 	 	 

[PLACEMENT AGREEMENT]

 

 

	 	 	 	 	 

SCHEDULE I

	 	 	 	 	 
	 	 	Principal	 
	 	 	amount of	 
	 	 	Securities to	 
	Placement Agent	 	be Purchased	 
	 
	 	 	 	 
	Banc of America Securities LLC
	 	$	165,000,000	 
	J.P. Morgan Securities Inc.
	 	 	45,000,000	 
	Scotia Capital (USA) Inc.
	 	 	60,000,000	 
	BBVA Securities Inc.
	 	 	15,000,000	 
	BMO Capital Markets Corp.
	 	 	15,000,000	 
	Total:
	 	$	300,000,000	 
	 
	 	 	 

 

 

SCHEDULE II

	 		
	PRICING SUPPLEMENT
	 	STRICTLY CONFIDENTIAL

$300,000,000

KANSAS
CITY SOUTHERN DE MÉXICO, S.A. DE C.V.

8% Senior Notes due 2018

January 7, 2010 

This Pricing Supplement is qualified in its entirety by reference to the Preliminary Offering
Memorandum dated January 7, 2010 (the “Preliminary Offering Memorandum”). The information in this
Pricing Supplement supplements the Preliminary Offering Memorandum and supersedes the information
in the Preliminary Offering Memorandum to the extent this information is inconsistent with the
information in the Preliminary Offering Memorandum. Capitalized terms used in this Pricing
Supplement but not defined have the meanings given to them in the Preliminary Offering Memorandum.

The Notes have not been registered under the Securities Act of 1933, as amended (the “Securities
Act”), and may not be offered or sold, except pursuant to an exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act. Accordingly, the Notes are
being offered and sold (1) only to “qualified institutional buyers” (as defined in Rule 144A under
the Securities Act) and (2) outside the United States to non-U.S. persons in compliance with
Regulation S under the Securities Act.

The Notes have not been and will not be registered with the Mexican National Securities Registry
(Registro Nacional de Valores) maintained by the Mexican National Banking and Securities Commission
(Comisión Nacional Bancaria y de Valores) and may not be offered or sold publicly, or otherwise be
the subject of broker activities in Mexico, except pursuant to a private placement exemption set
forth under Article 8 of the Mexican Securities Market Law (Ley del Mercado de Valores).

	 	 	 
	Issuer:

	 	Kansas City Southern de México, S.A. de C.V.
	 
	 	 
	Aggregate Principal Amount:

	 	 $300,000,000 
	 
	 	 
	Title of Securities:

	 	8% Senior Notes due 2018 (the “Notes”)
	 
	 	 
	Final Maturity Date:

	 	February 1, 2018
	 
	 	 
	Issue Price:

	 	 98.55% plus accrued interest from January 22, 2010.
	 
	 	 
	Coupon

	 	 8.00% 
	 
	 	 
	Yield to Maturity

	 	 8.25% 
	 
	 	 
	Gross Proceeds

	 	$295,650,000 before placement agents’ discounts
and estimated offering expenses.
	 
	 	 
	Interest Payment Dates:

	 	February 1 and August 1
	 
	 	 
	Record Dates:

	 	January 15 and July 15
	 
	 	 
	First Interest Payment Date:

	 	August 1, 2010

 

 

	 	 	 
	Optional Redemption:

	 	After February 1, 2014, the Company may, at its
option, redeem the Notes in whole at any time or
in whole or in part from time to time, upon not
less than 30 nor more than 60 days’ notice, at the
following redemption prices (expressed as
percentages of the principal amount thereof) if
redeemed during the 12-month period commencing on
February 1 of the year set forth below, plus, in
each case, accrued interest, liquidated damages,
if any, and any Additional Amounts:

	 	 	 	 	 
	Year	 	Percentage
	2014
	 	 	104.000	%
	2015
	 	 	102.000	%
	2016 and thereafter
	 	 	100.000	%

	 	 	 
	Optional Redemption with
Equity Proceeds:

	 	At any time on or prior to February 1, 2013, the
Company may redeem up to 35% of the aggregate
principal amount of outstanding Notes issued under
the Indenture at a redemption price of 108.000% of
their principal amount, plus accrued interest and
liquidated damages, if any, and any Additional
Amounts to the redemption date, with the Net Cash
Proceeds of one or more Equity Offerings of KCSM
or KCS, to the extent the Net Cash Proceeds
thereof are contributed to KCSM or used to
purchase Capital Stock (other than Disqualified
Stock) of KCSM from KCSM; provided, that: (1) at
least 65% of the aggregate principal amount of
Notes issued under the Indenture remains
outstanding immediately after the occurrence of
such redemption (excluding Notes held by the
Company and its Subsidiaries); and (2) the
redemption occurs within 60 days of the date of
the closing of such Equity Offering.
	 
	 	 
	Additional Optional
Redemption:

	 	Upon completion of the registered exchange offer
as described under “Description of the
Notes—Registered Exchange Offer; Registration
Rights,” the Company may also redeem any Notes
which were not exchanged in the registered
exchange offer in an amount up to 2% of the
original aggregate principal amount of Notes
issued at a redemption price of 100% of their
principal amount plus accrued interest, liquidated
damages, if any, and any Additional Amounts to the
redemption date.
	 
	 	 
	 

	 	In addition, the Company may, at its option,
redeem the Notes at any time at a redemption price
of 100% of their principal amount plus accrued
interest, liquidated damages, if any, and any
Additional Amounts to the redemption date if the
Mexican withholding tax rate on payments of
interest in respect of the Notes is increased, as
a result of a change in Mexican law, to a rate in
excess of 4.9%.
	 
	 	 
	Placement Agents:

	 	Banc of America Securities LLC

J.P. Morgan Securities Inc.

Scotia Capital (USA) Inc.

BBVA Securities Inc.

BMO Capital Markets Corp.
	 
	 	 
	Trade Date:

	 	January 7, 2010
	 
	 	 
	Settlement Date:

	 	January 22, 2010 (T+10 business days)
	 
	 	 
	144A CUSIP/ISIN Numbers:

	 	485161 AG8 / US485161AG83
	 
	 	 
	Reg S CUSIP/ISIN Numbers:

	 	P6052A AD6 / USP6052AAD65

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]